1. Home
  2. STAA vs MIRM Comparison

STAA vs MIRM Comparison

Compare STAA & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • MIRM
  • Stock Information
  • Founded
  • STAA 1982
  • MIRM 2018
  • Country
  • STAA United States
  • MIRM United States
  • Employees
  • STAA N/A
  • MIRM N/A
  • Industry
  • STAA Ophthalmic Goods
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • STAA Health Care
  • MIRM Health Care
  • Exchange
  • STAA Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • STAA 850.9M
  • MIRM 2.5B
  • IPO Year
  • STAA N/A
  • MIRM 2019
  • Fundamental
  • Price
  • STAA $17.17
  • MIRM $52.66
  • Analyst Decision
  • STAA Hold
  • MIRM Strong Buy
  • Analyst Count
  • STAA 8
  • MIRM 9
  • Target Price
  • STAA $27.17
  • MIRM $66.22
  • AVG Volume (30 Days)
  • STAA 758.1K
  • MIRM 465.4K
  • Earning Date
  • STAA 08-06-2025
  • MIRM 08-06-2025
  • Dividend Yield
  • STAA N/A
  • MIRM N/A
  • EPS Growth
  • STAA N/A
  • MIRM N/A
  • EPS
  • STAA N/A
  • MIRM N/A
  • Revenue
  • STAA $279,134,000.00
  • MIRM $379,251,000.00
  • Revenue This Year
  • STAA N/A
  • MIRM $35.83
  • Revenue Next Year
  • STAA $27.83
  • MIRM $16.83
  • P/E Ratio
  • STAA N/A
  • MIRM N/A
  • Revenue Growth
  • STAA N/A
  • MIRM 69.31
  • 52 Week Low
  • STAA $13.50
  • MIRM $36.17
  • 52 Week High
  • STAA $49.86
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • STAA 49.02
  • MIRM 64.66
  • Support Level
  • STAA $16.52
  • MIRM $49.22
  • Resistance Level
  • STAA $18.00
  • MIRM $53.86
  • Average True Range (ATR)
  • STAA 0.69
  • MIRM 1.57
  • MACD
  • STAA 0.09
  • MIRM 0.08
  • Stochastic Oscillator
  • STAA 53.85
  • MIRM 79.63

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: